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A B S T R A C T
Proton pump inhibitors are commonly used in clinical practice for the treatment of 
peptic ulcer disease and gastro-esophageal reflux and are well tolerated by patients. 
Their use is rarely associated with hypersensitivity and anaphylactic reactions. Ac-
cording to the reports in the Uppsala Monitoring Center database the frequency 
of hypersensitivity reactions among all reported adverse reactions for proton pump 
inhibitors and H2-histamine receptor antagonists were between 0.2% and 0.7%. A 
few cases of hypersensitivity to lansoprazole have been reported. Herein, we report a 
patient who developed Kounis syndrome after taking 40 mg of lansoprazole. To our 
knowledge, this is the first report of Kounis syndrome associated with lansoprazole 
administration in the world literature.
I N T R O D U C T I O N
Proton pump inhibitors are the main medications currently used for the treatment 
of various gastrointestinal disorders. In cardiac patients these agents are usually pre-
scribed prophylactically in conjunction with aspirin and/or clopidogrel administration. 
They are non-competitive inhibitors of the parietal cell membrane enzyme H+/K+ 
adenosine triphosphatase. This enzyme acts as “acid pump” or “proton pump” which 
constitutes the final stage of the hydrochloric acid secretion in the stomach. They are 
metabolized in the liver via cytochrome P450. Their use is rarely associated with side-
effects and especially with hypersensitivity reactions. The following report concerns 
a patient who developed urticarial reaction after ingesting 30 mg of lansoprazole and 
immediately afterwards an acute inferior myocardial infarction presumably related to 
the allergic reaction to the medication1-4.
C A S E  R E P O R T
A 52-year-old man was transferred to the emergency department of our hospital 
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complaining of generalized itching, malaise, shortness of 
breath, difficulty in swallowing, and abdominal pain and numb-
ness over his entire body. On physical examination he had an 
erythematous skin rash covering the whole body with facial 
edema; he was diaphoretic, pale, and agitated. His symptoms 
started 10 min after receiving 30 mg of lansoprazole for his 
abdominal pain. He gave a history of previous peptic ulcer and 
hematemesis and was taking occasionally various antiulcer 
preparations including omeprazole and ranitidine with good 
tolerance. He was a non-smoker without any previous personal 
or family history of allergy or other drug sensitivity.
His blood pressure was 110/80 mmHg, the pulse rate 102 
beats/min regular and the electrocardiogram (ECG) was 
within normal limits (Fig. 1A). Pulse oximetry showed an 
oxygen saturation of 92%. He was treated with 500 mg of 
hydrocortisone sodium succinate and 4 mg of dimetindene 
(antihistamine) intravenously (IV). He also received inhalation 
of corticosteroid for difficulty in breathing.
However, while he was in the emergency room, he suddenly 
developed severe retrosternal pain radiating to both arms and 
started vomiting. A repeat ECG (Fig 1B) showed elevation 
of the ST-segment in leads II, III, aVF compatible with acute 
inferior wall myocardial infarction. His blood pressure dropped 
to 80/60 mmHg. At that time the patient was given a second 
bolus of 500 mg of hydrocortisone sodium succinate IV, 10 mg 
of morphine sulphate and a blood sample was taken for cardiac 
enzymes, troponin, histamine, tryptase, IgE immunoglobulins, 
complement protein and blood count.
The patient was subsequently admitted to the coronary 
care unit where he was thrombolyzed with a bolus dose of 
7000 IU of tenecteplace. His symptoms gradually subsided 
during the ensuing 24 hours and the ECG changes returned to 
normal (Fig. 1C). Echocardiographic examination performed 
at bedside revealed hypokinesia of the inferior wall with an 
estimated left ventricular ejection fraction of 50%. The results 
of blood testing showed increased troponin T of 1.5 ng/ml 
(normal range <0.1 μg/L) and peak creatine kinase (CK) of 
1342 IU/L with CK-MB of 150 IU/L. Blood eosinophils were 
raised to 9% but the complement proteins C3 and C4 were 
normal. Other specific blood measurements related to allergic 
FIGURE 1.
KOUNIS SYNDROME
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reactions were increased as follows: serum tryptase 20, 35, 
15 μg/l at 1, 2, 3 hours respectively (normal range 5.6-13.5), 
histamine 0.9 ng /L (normal range <0.2), immunoglobulin IgE 
190 IU/ml (normal range <110).
The patient underwent a treadmill stress test and a hy-
perventilation test which were normal. Oral test dose with 
lansoprazole was not performed in view of the acute myocar-
dial infarction as this was deemed clinically unsafe. However, 
a hypersensitivity skin test with lansoprazole (30 mg in 1 ml 
saline) was performed, which produced a wheal of 3 mm in 
diameter at 20 minutes. Similar testing with omeprazole (20 mg 
in 1ml saline), pantoprazole (20 mg in 1 ml saline), ranitidine 
(50 mg in ml saline) and buffered saline produced no reaction, 
thus confirming hypersensitivity limited to lansoprazole. The 
patient was discharged home on the seventh day of admis-
sion. Coronary angiography performed in the neighbouring 
university hospital showed 80% right coronary artery lesion 
and the patient underwent a successful coronary angioplasty 
and stenting procedure.
D I S C U S S I O N
To the best of our knowledge this is the first patient in 
the literature to develop acute myocardial infarction follow-
ing an allergic reaction after ingestion of lansoprazole. The 
association of an acute coronary syndrome and an allergic 
reaction has been suggested by Kounis (Kounis syndrome).1 
There are various drugs capable to induce Kounis syndrome5 
and include antibiotics, analgesics, antineoplastics, contrast 
media, intravenous anesthetics, corticosteroids, non-steroidal 
anti-inflammatory drugs, thrombolytics and skin disinfect-
ants. Few proton pump inhibitors used in everyday practice 
have been implicated on rare occasions in hypersensitivity 
reactions. The older preparations omeprazole6-10, lansopra-
zole11-14 and pantoprazole15-17 have all been, although rarely, 
associated with hypersensitivity reactions. A recent review of 
the literature14 has shown that only the newest proton pump 
inhibitors rabeprazol and esomeprazol are free, so far, of such 
reactions. Cross reactivity among the various brands has also 
been reported.12
The proton pump inhibitors are modified benzimidazoles 
containing the pyridine ring and they differ from each other in 
the substitution chains. They act by increasing the intragastric 
pH levels, which may enhance the effectiveness of the local 
immune response, reduce the washout of antibiotics from the 
gastric mucosa, and lower the minimal inhibitory concentra-
tions of pH-sensitive antibacterial agents.10
Our patient experienced an episode of generalized urti-
caria after oral intake of lansoprazole, which was followed by 
acute inferior myocardial infarction. The clinical presenta-
tion, the positive skin test to lansoprazole, the elevated IgE 
concentrations, and the raised serum histamime and tryptase 
levels suggest that an IgE mediated mechanism was involved 
in both reactions, namely, urticaria and acute myocardial 
infarction. During hypersensitivity reactions, vasoconstricting 
and collagen-degrading compounds are released locally and 
in peripheral circulation from activated mast cells. Preformed 
mediators, such as histamine, chymase, tryptase, neuropep-
tides, and proteoglycans, as well as newly synthesized media-
tors, such as arachidonic acid products, an array of chemokines 
and cytokines, and platelet activating factor 3 are some of 
them. Clinical and experimental studies18 have shown that 
these mediators can induce coronary artery spasm and/or acute 
myocardial infarction. In particular, histamine is raised in the 
coronary circulation of patients with variant angina and can 
induce tissue factor expression. Tryptase has been implicated 
in acute coronary syndromes and can degrade HDL. Indeed, 
tryptase and histamine were elevated in the serum of our pa-
tient during the hypersensitivity reaction and the subsequent 
acute myocardial infarction.
This report shows that the proton pump inhibitor lansopra-
zole can be an allergic trigger for acute myocardial infarction 
and should be added in the list of drugs capable to induce 
Kounis syndrome. Since cross reactivity between these agents 
has been proven, physicians should be aware of this risky as-
sociation and should always think about Kounis syndrome 
when they treat hypersensitivity complications induced by any 
of these compounds.
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